• Ampersand Management announced Marc Verbruggen was appointed managing director of portfolio company Purna Pharmaceuticals, effective June 1, 2026.
• Verbruggen joins from Normec Healthcare Belgium, where he served as managing director; he previously led Qualiphar as group CEO.
• Stefan Beyer moved from interim managing director to chairman of Purna’s board.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ampersand Management LLC published the original content used to generate this news brief on June 04, 2026, and is solely responsible for the information contained therein.